# Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors

> **NCT07385950** · — · NOT_YET_RECRUITING · sponsor: **Zhongnan Hospital** · enrollment: 100 (estimated)

## Conditions studied

- PET / CT
- Solid Tumors
- Adult

## Interventions

- **DIAGNOSTIC_TEST:** PET/CT Imaging with αvβ6/FAP-targeted tracer

## Key facts

- **NCT ID:** NCT07385950
- **Lead sponsor:** Zhongnan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385950, "Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07385950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*